Treating DR-TB is complicated from a programmatic perspective: treatment is individualised, tailored according to which drugs a patient is resistant to. It is long and taxing, requiring people to take a course of antibiotics for up to two years and endure often intolerable side effects, Kenya 2011. Photograph by Bruno De Cock
Technical brief |

The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions

A technical briefer sharing gaps and access priorities to ensure access to right diagnostics for Bundibugyo Ebola virus outbreak in DRC and Uganda.

DIAGNOSTICS RESEARCH AND DEVELOPMENT
Democratic Republic of the CongoUganda
Read more
Photograph by Bruno De Cock
A new Ebola testing machine is installed in the laboratory of Mongbwalu General Referral Hospital in Ituri eprovince, DR Congo. The equipment allows samples to be tested on site, reducing the need to transport them to Bunia and helping teams obtain results more quickly during the Ebola response. Photo Credit: Anna Schönhofer/MSF

Principles for equitable access to medical tools for Ebola disease caused by Bundibugyo virus

MSF calls for following R&D Principles for equitable access to medical tools for Bundibugyo virus
 

RESEARCH AND DEVELOPMENT
Read more
Photo Credit: Anna Schönhofer/MSF
Salah Aldeen - nurse – places an intravenous line to Marwa, 3 years. Marwa was admitted the day before, as she was presenting common symptoms of measles. Amir, her big brother, who lies in the next tent, was admitted 5 days earlier for the same reason. Photo Credit: Thibault Fendler/MSF
Press release |

Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings

Sustained funding, timely and unhindered access to vaccine supplies, and flexible, secure and adapted delivery models required to reach more people with lifesaving vaccination in world’s most fragile areas

VACCINES
Democratic Republic of the CongoSudan
Read more
Photo Credit: Thibault Fendler/MSF
MSF doctor Dr. Maham Khalid is examining four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab. Photo Credit: Gul Nayab
Press release |

MSF demands sustained investments and political will to end neglect of children with tuberculosis

1.2 million children have TB worldwide, but nearly half miss diagnosis and treatment 

TUBERCULOSIS
Central African RepublicDemocratic Republic of the CongoGuineaMozambiqueNigerNigeriaSouth SudanUgandaSomaliaPakistanAfghanistanPhilippines
Read more
Photo Credit: Gul Nayab

Latest News

What good is a breakthrough medicine if the people who need it can't afford it?

Video thumbnail
Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action
Video thumbnail
100 years of insulin
Video thumbnail
A Snapshot of the Access Campaign

Our work

COVID-19
Drug-resistant infections
Diabetes
Hepatitis C
HIV/AIDS
Tropical & neglected diseases
Tuberculosis
Vaccines
Patents & intellectual property
Research & development